These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 20085949)
1. Donor dopamine pretreatment and graft function after kidney transplantation. Ridgway D; Barrie J; Menon K JAMA; 2010 Jan; 303(3):230-1; author reply 231-2. PubMed ID: 20085949 [No Abstract] [Full Text] [Related]
2. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. Schnuelle P; Gottmann U; Hoeger S; Boesebeck D; Lauchart W; Weiss C; Fischereder M; Jauch KW; Heemann U; Zeier M; Hugo C; Pisarski P; Krämer BK; Lopau K; Rahmel A; Benck U; Birck R; Yard BA JAMA; 2009 Sep; 302(10):1067-75. PubMed ID: 19738091 [TBL] [Abstract][Full Text] [Related]
3. Donor dopamine pretreatment and graft function after kidney transplantation. Ball J; McAnulty G JAMA; 2010 Jan; 303(3):231; author reply 231-2. PubMed ID: 20085948 [No Abstract] [Full Text] [Related]
4. Donor dopamine pretreatment and graft function after kidney transplantation. Silverstein JH JAMA; 2010 Jan; 303(3):230; author reply 231-2. PubMed ID: 20085950 [No Abstract] [Full Text] [Related]
5. Dopamine in transplantation: Written off or comeback with novel indication? Schnuelle P; Benck U; Yard BA Clin Transplant; 2018 Jul; 32(7):e13292. PubMed ID: 29790212 [TBL] [Abstract][Full Text] [Related]
6. Hydrogen Sulfide Treatment Mitigates Renal Allograft Ischemia-Reperfusion Injury during Cold Storage and Improves Early Transplant Kidney Function and Survival Following Allogeneic Renal Transplantation. Lobb I; Davison M; Carter D; Liu W; Haig A; Gunaratnam L; Sener A J Urol; 2015 Dec; 194(6):1806-15. PubMed ID: 26239336 [TBL] [Abstract][Full Text] [Related]
7. The effects of diltiazem and dopamine on early graft function in renal transplant recipients. Dönmez A; Karaaslan D; Sekerci S; Akpek E; Karakayali H; Arslan G Transplant Proc; 1999 Dec; 31(8):3305-6. PubMed ID: 10616487 [No Abstract] [Full Text] [Related]
8. Controlled Rewarming after Hypothermia: Adding a New Principle to Renal Preservation. Schopp I; Reissberg E; Lüer B; Efferz P; Minor T Clin Transl Sci; 2015 Oct; 8(5):475-8. PubMed ID: 26053383 [TBL] [Abstract][Full Text] [Related]
9. Biological modulation of renal ischemia-reperfusion injury. Snoeijs MG; van Heurn LW; Buurman WA Curr Opin Organ Transplant; 2010 Apr; 15(2):190-9. PubMed ID: 20009928 [TBL] [Abstract][Full Text] [Related]
10. DCD kidney transplantation: results and measures to improve outcome. Hoogland ER; Snoeijs MG; van Heurn LW Curr Opin Organ Transplant; 2010 Apr; 15(2):177-82. PubMed ID: 20125021 [TBL] [Abstract][Full Text] [Related]
11. Fenoldopam vs dopamine as a nephroprotective strategy during living donor kidney transplantation: preliminary data. Sorbello M; Morello G; Paratore A; Cutuli M; Mistretta G; Belluoccio AA; Veroux M; Veroux P; Macarone M; Gagliano M; Mangianeli S Transplant Proc; 2007; 39(6):1794-6. PubMed ID: 17692615 [TBL] [Abstract][Full Text] [Related]
12. Acute renal failure after liver transplantation: the role of dopamine and fenoldopam. Leung N; Textor SC Liver Transpl; 2004 Aug; 10(8):993-4. PubMed ID: 15390324 [No Abstract] [Full Text] [Related]
13. Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats. Cassis P; Azzollini N; Solini S; Mister M; Aiello S; Cugini D; Scudeletti P; Gagliardini E; Abbate M; Gallon L; Remuzzi G; Noris M Transplantation; 2011 Aug; 92(3):271-9. PubMed ID: 21705971 [TBL] [Abstract][Full Text] [Related]
14. Improved renal graft function after prostacyclin pretreatment. Mühlbacher F; Sautner T; Schemper M Transplant Proc; 1987 Oct; 19(5):4162-3. PubMed ID: 3314008 [No Abstract] [Full Text] [Related]
15. Economic impact of the introduction of machine perfusion preservation in a kidney transplantation program in the expanded donor era: cost-effectiveness assessment. Gómez V; Galeano C; Diez V; Bueno C; Díaz F; Burgos FJ Transplant Proc; 2012 Nov; 44(9):2521-4. PubMed ID: 23146442 [TBL] [Abstract][Full Text] [Related]
16. Effect of N-acetyl-cysteine (NAC) added to fenoldopam or dopamine on end-tidal carbon dioxide and mean arterial pressure at time of renal artery declamping during cadaveric kidney transplantation. Sorbello M; Morello G; Parrinello L; Molino C; Rinzivillo D; Pappalardo R; Cutuli M; Corona D; Veroux P; Veroux M Transplant Proc; 2010 May; 42(4):1056-60. PubMed ID: 20534223 [TBL] [Abstract][Full Text] [Related]
17. Low-dose dopamine in kidney transplantation. Ciapetti M; di Valvasone S; di Filippo A; Cecchi A; Bonizzoli M; Peris A Transplant Proc; 2009 Dec; 41(10):4165-8. PubMed ID: 20005360 [TBL] [Abstract][Full Text] [Related]
18. Tailored dialysis start may allow persistence of residual renal function after graft failure: a case report. Piccoli GB; Motta D; Gai M; Mezza E; Maddalena E; Bravin M; Tattoli F; Consiglio V; Burdese M; Bilucaglia D; Ferrari A; Segoloni GP Transplant Proc; 2004 Nov; 36(9):2607-9. PubMed ID: 15621101 [TBL] [Abstract][Full Text] [Related]
19. Advances in immunosuppression for kidney transplantation: new strategies for preserving kidney function and reducing cardiovascular risk. Bestard O; Campistol JM; Morales JM; Sánchez-Fructuoso A; Cabello M; Cabello V; Pallardó LM; Grinyó JM Nefrologia; 2012 May; 32(3):374-84. PubMed ID: 22535159 [TBL] [Abstract][Full Text] [Related]
20. Current literature questions the routine use of low-dose dopamine. Abay MC; Reyes JD; Everts K; Wisser J AANA J; 2007 Feb; 75(1):57-63. PubMed ID: 17304785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]